Cannara Biotech Balance Sheet

Financials in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 28, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021
Cash & Equivalents	21.9	14.36	6.62	4.27	12.11	8.16
Cash & Short-Term Investments	21.9	14.36	6.62	4.27	12.11	8.16
Cash Growth	333.25%	116.91%	55.02%	-64.75%	48.48%	4.99%
Accounts Receivable	12.47	14.11	13.04	10.59	8.62	2.92
Other Receivables	-	-	-	-	-	0.05
Receivables	12.47	14.11	13.04	10.59	8.62	2.97
Inventory	54.15	51.33	40.07	33.77	18.98	7.41
Prepaid Expenses	2.6	2.36	2.85	3.06	1.28	0.71
Other Current Assets	-	-	4.9	-	-	-
Total Current Assets	91.13	82.16	67.47	51.7	40.99	19.25
Property, Plant & Equipment	89.87	86	84.94	89.44	83.4	71.75
Long-Term Accounts Receivable	-	-	-	-	-	0.07
Long-Term Deferred Tax Assets	-	-	1.95	-	-	-
Long-Term Deferred Charges	0.16	0.05	-	0.06	-	-
Other Long-Term Assets	0.65	0.44	0.36	0.33	1.22	0.95
Total Assets	181.81	168.65	154.72	141.52	125.62	92.02
Accounts Payable	11.58	11	9.42	8.12	8.85	6.19
Accrued Expenses	9	9.77	7.94	6.86	0.77	0.07
Short-Term Debt	6.76	6.76	6.26	3	-	-
Current Portion of Long-Term Debt	2.02	6.26	2.97	2.97	1.97	0.3
Current Portion of Leases	0.22	0.28	0.28	0.08	0.22	0.23
Current Unearned Revenue	0.2	0.13	0.13	0.16	0.05	0.04
Total Current Liabilities	29.79	34.2	27	21.18	11.86	6.83
Long-Term Debt	25.2	28.17	38.45	39.64	46.19	20.15
Long-Term Leases	0.02	0.11	0.37	0.1	0.02	0.22
Long-Term Unearned Revenue	1.37	0.88	0.94	0.86	0.82	0.71
Long-Term Deferred Tax Liabilities	5.22	3.07	-	-	-	-
Total Liabilities	61.6	66.43	66.77	61.78	58.88	27.91
Common Stock	104.1	89.76	88.52	88.8	83.3	83.21
Additional Paid-In Capital	13.23	12.28	12.33	10.35	9.72	9.41
Retained Earnings	2.88	0.18	-12.9	-19.34	-26.3	-28.61
Comprehensive Income & Other	-	-	-	-0.07	0.02	0.1
Total Common Equity	120.21	102.22	87.95	79.74	66.74	64.12
Shareholders' Equity	120.21	102.22	87.95	79.74	66.74	64.12
Total Liabilities & Equity	181.81	168.65	154.72	141.52	125.62	92.02
Total Debt	34.22	41.58	48.33	45.78	48.39	20.9
Net Cash (Debt)	-12.32	-27.22	-41.71	-41.51	-36.28	-12.74
Net Cash Per Share	-0.13	-0.29	-0.46	-0.46	-0.41	-0.17
Filing Date Shares Outstanding	98.78	94.9	90.02	90.02	87.7	87.65
Total Common Shares Outstanding	98.78	91.43	90.02	90.31	87.7	87.65
Working Capital	61.34	47.96	40.47	30.51	29.13	12.41
Book Value Per Share	1.22	1.12	0.98	0.88	0.76	0.73
Tangible Book Value	120.21	102.22	87.95	79.74	66.74	64.12
Tangible Book Value Per Share	1.22	1.12	0.98	0.88	0.76	0.73
Land	2.33	2.33	2.33	2.45	2.45	2.45
Buildings	78.42	77.76	76.71	75.48	64.3	44.79
Machinery	27.89	25.49	20.65	18.57	14.22	8.47
Construction In Progress	8.45	4.65	4.71	6.73	11.53	21.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.